Literature DB >> 20459819

Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.

Hilde M H Braakman1, Jan Lodder, Alida A Postma, Lambert F R Span, Werner H Mess.   

Abstract

BACKGROUND: The aetiology of central nervous system lesions observed in cerebral cyclosporine neurotoxicity remains controversial. CASE
PRESENTATION: We report a 48-year-old woman with a non-severe aplastic anaemia who presented with stroke-like episodes while on cyclosporine treatment.Transcranial Doppler ultrasound revealed severely elevated flow velocities in several cerebral vessels, consistent with vasospasm. Immediately after reducing the cyclosporine dose, the stroke-like episodes disappeared. Only after cyclosporine withdrawal the transcranial Doppler ultrasound abnormalities fully resolved.
CONCLUSIONS: This case demonstrates a significant role of vasospasm in the pathway of cyclosporine-induced neurotoxicity. Transcranial Doppler ultrasound is an effective tool for the diagnosis and follow-up of cyclosporine-induced vasospasm.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459819      PMCID: PMC2874792          DOI: 10.1186/1471-2377-10-30

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  13 in total

1.  Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia.

Authors:  Paul Greaves; Heather Oakervee; Samantha S C Kon; Randall Jones; Nadine Farah
Journal:  Br J Haematol       Date:  2006-08       Impact factor: 6.998

Review 2.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

3.  Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.

Authors:  W S Bartynski; Z Zeigler; M P Spearman; L Lin; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

4.  Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity.

Authors:  W S Bartynski; B C Grabb; Z Zeigler; L Lin; D F Andrews
Journal:  J Comput Assist Tomogr       Date:  1997 Nov-Dec       Impact factor: 1.826

5.  Cyclosporin A-related cerebral vasculopathy.

Authors:  R M Shbarou; N J Chao; J C Morgenlander
Journal:  Bone Marrow Transplant       Date:  2000-10       Impact factor: 5.483

Review 6.  Biochemical mechanisms of cyclosporine neurotoxicity.

Authors:  Natalie J Serkova; Uwe Christians; Leslie Z Benet
Journal:  Mol Interv       Date:  2004-04

7.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

8.  Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy.

Authors:  Jen-Tsun Lin; Shuu-Jiun Wang; Jong-Ling Fuh; Lian-Tsai Hsiao; Jiing-Feng Lirng; Po-Min Chen
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

9.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

10.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

View more
  1 in total

1.  [Nervous system side effects of disease modifying treatments of rheumatoid arthritis].

Authors:  A Rubbert-Roth; H-F Petereit
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.